Amerise Biosciences Ltd — Important, 09-04-2026: Company Update

Amerise Biosciences announced it is not required to submit the Annual Secretarial Compliance Report. The company qualifies for an exemption from certain corporate governance provisions, as its paid-up equity capital is consistently below 10 Cr and net worth below 25 Cr. For instance, in the last financial year, paid-up capital was 6.61 Cr and net worth was 5.40 Cr. This exemption simplifies the company's compliance requirements, indicating a lean operational structure and potentially lowering administrative burdens. This update clarifies the company's compliance status for investors.